Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Diagnosis of lung cancer depends on lung histology or sputum shedding cytology. Screening methods for lung cancer mainly include X-ray chest X-ray and sputum cytology, low-dose spiral CT, blood and sputum biomarkers, and exhalation gas monitoring.
As people's awareness of cancer increases and technology advances, as well as private and government support, these are some of the factors that are expected to drive market growth.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Lung Cancer Diagnostics market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Lung Cancer Diagnostics market. Detailed analysis of key players, along with key growth strategies adopted by Lung Cancer Diagnostics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
AstraZeneca plc
Illumina Inc
bioMérieux
Qiagen NV
Roche Diagnostics
Sanofi SA
Thermo Fisher Scientific
Agilent Technologies
Janssen
By Type:
Biopsy
Imaging Test
Molecular Test
Sputum Cytology
Others
By End-User:
Hospital
Clinic
Other
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Lung Cancer Diagnostics Market
-
1.3 Market Segment by Type
-
1.3.1 USA Lung Cancer Diagnostics Market Size and Growth Rate of Biopsy from 2016 to 2027
-
1.3.2 USA Lung Cancer Diagnostics Market Size and Growth Rate of Imaging Test from 2016 to 2027
-
1.3.3 USA Lung Cancer Diagnostics Market Size and Growth Rate of Molecular Test from 2016 to 2027
-
1.3.4 USA Lung Cancer Diagnostics Market Size and Growth Rate of Sputum Cytology from 2016 to 2027
-
1.3.5 USA Lung Cancer Diagnostics Market Size and Growth Rate of Others from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Lung Cancer Diagnostics Market Size and Growth Rate of Hospital from 2016 to 2027
-
1.4.2 USA Lung Cancer Diagnostics Market Size and Growth Rate of Clinic from 2016 to 2027
-
1.4.3 USA Lung Cancer Diagnostics Market Size and Growth Rate of Other from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Lung Cancer Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Lung Cancer Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Lung Cancer Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Lung Cancer Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Lung Cancer Diagnostics Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Lung Cancer Diagnostics by Major Types
-
3.4.1 Market Size and Growth Rate of Biopsy
-
3.4.2 Market Size and Growth Rate of Imaging Test
-
3.4.3 Market Size and Growth Rate of Molecular Test
-
3.4.4 Market Size and Growth Rate of Sputum Cytology
-
3.4.5 Market Size and Growth Rate of Others
4 Segmentation of Lung Cancer Diagnostics Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Lung Cancer Diagnostics by Major End-Users
-
4.4.1 Market Size and Growth Rate of Lung Cancer Diagnostics in Hospital
-
4.4.2 Market Size and Growth Rate of Lung Cancer Diagnostics in Clinic
-
4.4.3 Market Size and Growth Rate of Lung Cancer Diagnostics in Other
5 Market Analysis by Regions
-
5.1 USA Lung Cancer Diagnostics Production Analysis by Regions
-
5.2 USA Lung Cancer Diagnostics Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Lung Cancer Diagnostics Landscape Analysis
-
6.1 West USA Lung Cancer Diagnostics Landscape Analysis by Major Types
-
6.2 West USA Lung Cancer Diagnostics Landscape Analysis by Major End-Users
7 South USA Lung Cancer Diagnostics Landscape Analysis
-
7.1 South USA Lung Cancer Diagnostics Landscape Analysis by Major Types
-
7.2 South USA Lung Cancer Diagnostics Landscape Analysis by Major End-Users
8 Middle West USA Lung Cancer Diagnostics Landscape Analysis
-
8.1 Middle West USA Lung Cancer Diagnostics Landscape Analysis by Major Types
-
8.2 Middle West USA Lung Cancer Diagnostics Landscape Analysis by Major End-Users
9 Northeast USA Lung Cancer Diagnostics Landscape Analysis
-
9.1 Northeast USA Lung Cancer Diagnostics Landscape Analysis by Major Types
-
9.2 Northeast USA Lung Cancer Diagnostics Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 AstraZeneca plc
-
10.1.1 AstraZeneca plc Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Illumina Inc
-
10.2.1 Illumina Inc Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 bioMérieux
-
10.3.1 bioMérieux Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Qiagen NV
-
10.4.1 Qiagen NV Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Roche Diagnostics
-
10.5.1 Roche Diagnostics Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Sanofi SA
-
10.6.1 Sanofi SA Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Thermo Fisher Scientific
-
10.7.1 Thermo Fisher Scientific Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Agilent Technologies
-
10.8.1 Agilent Technologies Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Janssen
-
10.9.1 Janssen Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Lung Cancer Diagnostics Market Size and Growth Rate of Biopsy from 2016 to 2027
-
Figure USA Lung Cancer Diagnostics Market Size and Growth Rate of Imaging Test from 2016 to 2027
-
Figure USA Lung Cancer Diagnostics Market Size and Growth Rate of Molecular Test from 2016 to 2027
-
Figure USA Lung Cancer Diagnostics Market Size and Growth Rate of Sputum Cytology from 2016 to 2027
-
Figure USA Lung Cancer Diagnostics Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Lung Cancer Diagnostics Market Size and Growth Rate of Hospital from 2016 to 2027
-
Figure USA Lung Cancer Diagnostics Market Size and Growth Rate of Clinic from 2016 to 2027
-
Figure USA Lung Cancer Diagnostics Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Lung Cancer Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Lung Cancer Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Lung Cancer Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Lung Cancer Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Lung Cancer Diagnostics Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Lung Cancer Diagnostics
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Lung Cancer Diagnostics by Different Types from 2016 to 2027
-
Table Consumption Share of Lung Cancer Diagnostics by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Biopsy
-
Figure Market Size and Growth Rate of Imaging Test
-
Figure Market Size and Growth Rate of Molecular Test
-
Figure Market Size and Growth Rate of Sputum Cytology
-
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Lung Cancer Diagnostics by Different End-Users from 2016 to 2027
-
Table Consumption Share of Lung Cancer Diagnostics by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospital
-
Figure Market Size and Growth Rate of Clinic
-
Figure Market Size and Growth Rate of Other
-
Table USA Lung Cancer Diagnostics Production by Regions
-
Table USA Lung Cancer Diagnostics Production Share by Regions
-
Figure USA Lung Cancer Diagnostics Production Share by Regions in 2016
-
Figure USA Lung Cancer Diagnostics Production Share by Regions in 2021
-
Figure USA Lung Cancer Diagnostics Production Share by Regions in 2027
-
Table USA Lung Cancer Diagnostics Consumption by Regions
-
Table USA Lung Cancer Diagnostics Consumption Share by Regions
-
Figure USA Lung Cancer Diagnostics Consumption Share by Regions in 2016
-
Figure USA Lung Cancer Diagnostics Consumption Share by Regions in 2021
-
Figure USA Lung Cancer Diagnostics Consumption Share by Regions in 2027
-
Table West USA Lung Cancer Diagnostics Consumption by Types from 2016 to 2027
-
Table West USA Lung Cancer Diagnostics Consumption Share by Types from 2016 to 2027
-
Figure West USA Lung Cancer Diagnostics Consumption Share by Types in 2016
-
Figure West USA Lung Cancer Diagnostics Consumption Share by Types in 2021
-
Figure West USA Lung Cancer Diagnostics Consumption Share by Types in 2027
-
Table West USA Lung Cancer Diagnostics Consumption by End-Users from 2016 to 2027
-
Table West USA Lung Cancer Diagnostics Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Lung Cancer Diagnostics Consumption Share by End-Users in 2016
-
Figure West USA Lung Cancer Diagnostics Consumption Share by End-Users in 2021
-
Figure West USA Lung Cancer Diagnostics Consumption Share by End-Users in 2027
-
Table South USA Lung Cancer Diagnostics Consumption by Types from 2016 to 2027
-
Table South USA Lung Cancer Diagnostics Consumption Share by Types from 2016 to 2027
-
Figure South USA Lung Cancer Diagnostics Consumption Share by Types in 2016
-
Figure South USA Lung Cancer Diagnostics Consumption Share by Types in 2021
-
Figure South USA Lung Cancer Diagnostics Consumption Share by Types in 2027
-
Table South USA Lung Cancer Diagnostics Consumption by End-Users from 2016 to 2027
-
Table South USA Lung Cancer Diagnostics Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Lung Cancer Diagnostics Consumption Share by End-Users in 2016
-
Figure South USA Lung Cancer Diagnostics Consumption Share by End-Users in 2021
-
Figure South USA Lung Cancer Diagnostics Consumption Share by End-Users in 2027
-
Table Middle West USA Lung Cancer Diagnostics Consumption by Types from 2016 to 2027
-
Table Middle West USA Lung Cancer Diagnostics Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Lung Cancer Diagnostics Consumption Share by Types in 2016
-
Figure Middle West USA Lung Cancer Diagnostics Consumption Share by Types in 2021
-
Figure Middle West USA Lung Cancer Diagnostics Consumption Share by Types in 2027
-
Table Middle West USA Lung Cancer Diagnostics Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Lung Cancer Diagnostics Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Lung Cancer Diagnostics Consumption Share by End-Users in 2016
-
Figure Middle West USA Lung Cancer Diagnostics Consumption Share by End-Users in 2021
-
Figure Middle West USA Lung Cancer Diagnostics Consumption Share by End-Users in 2027
-
Table Northeast USA Lung Cancer Diagnostics Consumption by Types from 2016 to 2027
-
Table Northeast USA Lung Cancer Diagnostics Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Lung Cancer Diagnostics Consumption Share by Types in 2016
-
Figure Northeast USA Lung Cancer Diagnostics Consumption Share by Types in 2021
-
Figure Northeast USA Lung Cancer Diagnostics Consumption Share by Types in 2027
-
Table Northeast USA Lung Cancer Diagnostics Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Lung Cancer Diagnostics Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Lung Cancer Diagnostics Consumption Share by End-Users in 2016
-
Figure Northeast USA Lung Cancer Diagnostics Consumption Share by End-Users in 2021
-
Figure Northeast USA Lung Cancer Diagnostics Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of AstraZeneca plc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca plc
-
Figure Sales and Growth Rate Analysis of AstraZeneca plc
-
Figure Revenue and Market Share Analysis of AstraZeneca plc
-
Table Product and Service Introduction of AstraZeneca plc
-
Table Company Profile and Development Status of Illumina Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Illumina Inc
-
Figure Sales and Growth Rate Analysis of Illumina Inc
-
Figure Revenue and Market Share Analysis of Illumina Inc
-
Table Product and Service Introduction of Illumina Inc
-
Table Company Profile and Development Status of bioMérieux
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of bioMérieux
-
Figure Sales and Growth Rate Analysis of bioMérieux
-
Figure Revenue and Market Share Analysis of bioMérieux
-
Table Product and Service Introduction of bioMérieux
-
Table Company Profile and Development Status of Qiagen NV
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Qiagen NV
-
Figure Sales and Growth Rate Analysis of Qiagen NV
-
Figure Revenue and Market Share Analysis of Qiagen NV
-
Table Product and Service Introduction of Qiagen NV
-
Table Company Profile and Development Status of Roche Diagnostics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche Diagnostics
-
Figure Sales and Growth Rate Analysis of Roche Diagnostics
-
Figure Revenue and Market Share Analysis of Roche Diagnostics
-
Table Product and Service Introduction of Roche Diagnostics
-
Table Company Profile and Development Status of Sanofi SA
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi SA
-
Figure Sales and Growth Rate Analysis of Sanofi SA
-
Figure Revenue and Market Share Analysis of Sanofi SA
-
Table Product and Service Introduction of Sanofi SA
-
Table Company Profile and Development Status of Thermo Fisher Scientific
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Thermo Fisher Scientific
-
Figure Sales and Growth Rate Analysis of Thermo Fisher Scientific
-
Figure Revenue and Market Share Analysis of Thermo Fisher Scientific
-
Table Product and Service Introduction of Thermo Fisher Scientific
-
Table Company Profile and Development Status of Agilent Technologies
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Agilent Technologies
-
Figure Sales and Growth Rate Analysis of Agilent Technologies
-
Figure Revenue and Market Share Analysis of Agilent Technologies
-
Table Product and Service Introduction of Agilent Technologies
-
Table Company Profile and Development Status of Janssen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Janssen
-
Figure Sales and Growth Rate Analysis of Janssen
-
Figure Revenue and Market Share Analysis of Janssen
-
Table Product and Service Introduction of Janssen
-
